3GWT image
Entry Detail
PDB ID:
3GWT
Keywords:
Title:
Catalytic domain of human phosphodiesterase 4B2B in complex with a quinoline inhibitor
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2009-04-01
Release Date:
2010-04-07
Method Details:
Experimental Method:
Resolution:
1.75 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
I 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:cAMP-specific 3',5'-cyclic phosphodiesterase 4B
Mutations:S654A, S659A, S661A
Chain IDs:A
Chain Length:353
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration.
Bioorg.Med.Chem.Lett. 19 5261 5265 (2009)
PMID: 19656678 DOI: 10.1016/j.bmcl.2009.04.012

Abstact

Crystallography driven optimisation of a lead derived from similarity searching of the GSK compound collection resulted in the discovery of quinoline-3-carboxamides as highly potent and selective inhibitors of phosphodiesterase 4B. This series has been optimized to GSK256066, a potent PDE4B inhibitor which also inhibits LPS induced production of TNF-alpha from isolated human peripheral blood mononuclear cells with a pIC(50) of 11.1. GSK256066 also has a suitable profile for inhaled dosing.

Legend

Protein

Chemical

Disease

Primary Citation of related structures